NIA Funding Line Policy for FY 2023
Update (3/31/2023): The information below reflects an update to the NIA funding policy for fiscal year (FY) 2023 in both the General Allocation and Alzheimer's Allocation categories.
NIA and NIH received an appropriation through the H.R.2617, the Consolidated Appropriations Act, 2023 which provides full-year funding through September 30, 2023.
NIA will now pay FY 2022 non-competing awards at 100% of the committed level as shown in the Notice of Award.
General Allocation
NIA is now reducing FY 2023 competing awards by 16% on average; this is a 2% reduction in cuts, meaning a 2% increase in funds awarded in comparison with our previous funding policy. This average cut policy applies to all research project awards except R03s (small grants), R21s (exploratory/developmental awards) and R15s (Academic Research Enhancement Awards and the NIH Research Enhancement Awards program). These awards (R03, R21, R15) generally receive the study-section-recommended amount of support. Additionally, all Early Stage Investigators (ESIs) and New Investigators (NIs) applications will not receive the reduction and will receive the study-section-recommended amount of support.
Note: The 16% cut remains an average. Individual awards may be reduced by more or less than that percentage. All previously awarded FY 2023 competing awards will be adjusted to reflect the new policy.
Alzheimer’s Allocation
NIA is paying awards at their full study section-recommended amounts, unless concerns about overlap or similar issues reduce the amount awarded.
Pay lines
Applications |
General pay line, < $500k |
General pay line, ≥ $500k |
AD/ADRD pay line |
---|---|---|---|
All (except below) |
15% |
12% |
25% |
New Investigator R01s |
18% |
15% |
28% |
Early Stage Investigator R01s |
20% |
17% |
30% |
Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may alternatively provide short-term support (R56) or invite a re-submission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the institute.
Applications |
General pay line |
AD/ADRD pay line |
---|---|---|
Program projects |
24 |
35 |
Other NIA-reviewed research |
24 |
35 |
Parent career development awards |
24 |
35 |
Parent fellowship awards |
30 |
40 |
Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may invite a re-submission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the institute.
All other categories of awards (Conference, Institutional Training, Small Business) are allocation-based rather than based on a funding line.